Area of research
Genetics · Epidemiology
Research interest
Research interests include Medicine, Inflammatory bowel disease, Pandemic, Coronavirus disease 2019 (COVID-19), Infliximab, and Vedolizumab.
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel